The other day I was attempting to help my 5 year old assemble a puzzle. I suggested to him that it might be easier to start with pieces that have smooth edges and to work from the outside in. As he is prone to do, he ignored me and promptly began fo…
My current role as CEO of American Clean Energy allow me to take a lead in resolving some of the state's energy distribution issues in an environmentally safe way using solar and other renewable energy technologies.
I was formerly the President, Chief Executive Officer and Chairman of the Board at Jersey Central Power and Light Company, the second largest electric utility in the state of New Jersey serving 1.1 million customers in half the towns and counties across the state. My background with FirstEnergy Corporation, the parent of JCP&L, spanned nearly 33 years and included engineering, operational management and executive positions across the three state service territory including parts of Ohio, Pennsylvania and New Jersey. In these roles I had responsibility for inception, design, construction, project management, testing and ongoing maintenance of complex electrical generation, transmission and distribution projects.
I have been active in a number of organizations and boards in New Jersey including the Board of the New Jersey Economic Development Authority; Rutgers University Institute of Marine and Coastal Science Board of Trustees; New Jersey Chamber of Commerce Board of Trustees, its Executive Board and Chairman of the Chamber Foundation; and Leadership New Jersey Board of Trustees. I have also been active in the Center for Environment, Energy and Economic Policy (CEEEP) at the Bloustein School at Rutgers and was involved in crafting the New Jersey Energy Master Plan.
For those that missed it, the CIO conference provided some in depth discussion on leveraging the cloud, pros and cons and the presumed role of the Cloud into the future. Some of the client concerns from the discussion were Security of Data on the Cl…
As enterprises consider the move to Windows 7 near term decisions as to whether or how to upgrade client hardware is critical. Enterprises should proactively build a five to eight year strategic client computing roadmap outlining an approach to devi…
Generic biologics – or biosimilars – are a new generation of pharmaceuticals. Companies ranging from established biopharma innovators and start-up biotechs to traditional small molecule generic houses are examining how to exploit the opportunities a…
Comment Wall
You need to be a member of New Jersey Technology Council Online Community to add comments!
Join New Jersey Technology Council Online Community